ImmunityBio (IBRX) Debt Ratio (2015 - 2026)

ImmunityBio (IBRX) posted quarterly Debt Ratio of 0.63 for Q1 2026, down 35.9% year-over-year from 0.98 in Q1 2025, and down 3.33% quarter-over-quarter from 0.65 in Q4 2025.

ImmunityBio (IBRX) Debt Ratio (2015 - 2026) Analysis & Trends

ImmunityBio (IBRX) has reported Debt Ratio for 12 consecutive years, with 0.63 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio fell 35.9% year-over-year to 0.63; the TTM figure through Mar 2026 stood at 0.63 (down 35.9% YoY), while the FY2025 annual figure was 0.65, down 12.92% from the prior year.
  • Debt Ratio eased to 0.63 in Q1 2026 per IBRX's latest filing, from 0.65 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.11 in Q3 2023 and bottomed at 0.24 in Q2 2024.
  • Historically, Debt Ratio has averaged 0.69 across 5 years, with a median of 0.72 in 2023.
  • Annual changes were most pronounced in 2024 — Debt Ratio slumped 72.54% — and 2025, when it surged 211.84%.
  • ImmunityBio's Debt Ratio stood at 1.06 in 2022, then slumped by 70.87% to 0.31 in 2023, then surged by 141.07% to 0.74 in 2024, then slipped by 12.92% to 0.65 in 2025, then fell by 3.33% to 0.63 in 2026.
  • Business Quant data shows IBRX's Debt Ratio at 0.63 in Q1 2026, 0.65 in Q4 2025, and 0.61 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 ImmunityBio 7.97 Bn 7.62 Bn 50.94 Mn 0.66

Historic Data

Download Data
DateValue
Jun 30, 2026 0.66
Mar 31, 2026 0.63
Dec 31, 2025 0.65
Sep 30, 2025 0.61
Jun 30, 2025 0.76
Mar 31, 2025 0.98
Dec 31, 2024 0.74
Sep 30, 2024 0.30
Jun 30, 2024 0.24
Mar 31, 2024 0.41
Dec 31, 2023 0.31
Sep 30, 2023 1.11
Mar 31, 2023 0.72
Sep 30, 2022 1.06
Jun 30, 2022 0.98
Mar 31, 2022 0.79
Sep 30, 2021 1.45
Jun 30, 2021 1.29
Mar 31, 2021 1.50
Dec 31, 2020 1.22